Jun 24, 2025, 20:58
Saving Lives with Guidelines? ISTH 2025: Prophylactic Anticoagulation Reduces VTE by 60% and Mortality by 56%
Marc Carrier posted on X:
”Implementation matters! A guideline-driven VTE prevention program (Vermont Model) led to ~60% of high-risk cancer patients receiving prophylactic anticoagulation—resulting in a 60% reduction in VTE and 56% reduction in death. ISTH 2025, VTE Prevention”
ISTH 2025 is full of surprises we didn’t know we needed. Turns out, guidelines bring common sense to life—eventually!
Marc Carrier, MD, MSc, FRCPC, urges us to adopt the Vermont Model for prophylactic anticoagulation, in pursuit of grand reductions in VTE and death among high-risk cancer patients.
To stay updated on the world of thrombosis, be sure to subscribe to Hemostasis Today.
-
Jan 10, 2026, 08:56Shivanand Kumatagi Reflects on His Visit to Rela Hospital
-
Jan 10, 2026, 08:48Mitchell Elkind: Why Is The American Heart Association Holding a Brain Health Symposium?
-
Jan 10, 2026, 08:41Fiona Robinson Invites You to NBDF Webinar on Research Grants
-
Jan 10, 2026, 08:30Melissa Korn Takes Front Page Award for Her WSJ Piece on Experiencing a Pulmonary Embolism
-
Jan 10, 2026, 08:20Aymar Akilimali on Malaria in the Democratic Republic of Congo
-
Jan 9, 2026, 12:17Louise St Germain Bannon Invites You to Self-Nominate for the ISTH Council
-
Jan 9, 2026, 09:25Emma Groarke Shares A Comprehensive Review on VEXAS Syndrome
-
Jan 9, 2026, 09:13Anirban Sen Gupta Presents PlateChek
-
Jan 9, 2026, 08:58Oscar Pena Shares KDIGO 2026 Update: 5 Critical Changes for Anemia in CKD Management